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THE EFFICACY OF A LATERAL WEDGE INSOLE FOR PAINFUL MEDIAL KNEE 
OSTEOARTHRITIS AFTER PRESCREENING : A RANDOMIZED CLINICAL TRIAL 
ABSTRACT  
Objective: Lateral wedge shoe insoles decrease medial knee loading, but trials have shown 
no effect on pain in medial knee osteoarthritis (OA). However, insoles’ loading effects are 
inconsistent, and they can increase patellofemoral loading. We hypothesized that insoles 
would reduce pain in preselected patients.  
Methods: In persons with painful medial knee OA, we excluded those with patellofemoral OA 
and those with pain <4/10. We further excluded participants who, in a gait laboratory using 
lateral wedges, did not show at least a 2% reduction in knee adduction moment (KAM) 
compared with their shoes and a neutral insole. We then randomized subjects to lateral wedge 
vs. neutral insole for 8 week periods separated by an 8 week washout. Primary outcome was 
knee pain over the past week (0-10) and secondary outcomes nominated activity pain and 
KOOS pain. We carried out mixed model analyses adjusted for baseline pain.  
Results: Of 83 participants, 21 (25%) were excluded because of insufficient reduction in KAM. 
Of 62 included, mean age was 64.2 years (SD 9.1); 37.1% were women. Lateral wedge insoles 
produced a greater reduction in knee pain than neutral insoles (difference 0.7 on 0-10 scale; 
95%CI 0.1, 1.2; p = 0.02).  Secondary outcomes showed mixed findings.  
Conclusions: In persons prescreened to eliminate those with patellofemoral OA and 
biomechanical non-responders, lateral wedge insoles reduced knee pain, but the effect of 
treatment was small and is likely of clinical significance in only a minority of patients.  
Targeting patients may identify those who respond to this treatment.   
Roughly 12% of persons aged 60 and over have painful knee osteoarthritis (OA) (1). 
Rates of knee replacement have been rising in large part because of the failure of medical and 
rehabilitative treatments. New treatments for knee OA are badly needed.  
Lateral wedge insoles placed inside shoes shift loading across the knee laterally during 
walking. They reduce load across the medial knee where most affected persons have either 
isolated disease or disease combined with involvement of the patellofemoral joint. Lateral 
wedge insoles reduce the external knee adduction moment (KAM), a measure of the load 
across the medial vs. lateral compartment, by 5-6%  (2, 3). Unfortunately, in trials, lateral 
wedges have not reduced knee pain compared with neutral insoles. In a metaanalysis by 
Parkes et al. (4), all eight randomized controlled trials comparing lateral wedge to neutral 
insoles were null, and the effect size on pain reduction was 0.03 (95% confidence interval -
0.18, 0.22). A subsequently published trial also was negative (5).  
In 25% of patients, the wedge does not reduce medial load (6, 7). Furthermore, OA in 
the patellofemoral joint may get worse as load is shifted laterally. We therefore hypothesized 
that if we selected persons with painful medial compartment knee OA who showed a 
biomechanical response to wedge insoles and did not have painful patellofemoral OA, they 
would experience a reduction in knee pain compared with neutral insoles.  
Because use of a shoe insole is a simple, low-cost intervention, its efficacy in reducing 
pain could translate into large public health benefit and possibly widespread use. Further, 
medial knee OA is highly prevalent not only in Western countries but in developing ones where 
knee replacements are not widely available. We conducted a crossover trial testing a 5° lateral 
wedge insole, the same insole we and others tested previously (8).   
METHODS  
This was a randomized trial testing lateral wedge insoles vs. neutral insoles in persons 
with painful medial knee osteoarthritis. The clinical trial registration number was 
ISRCTN55059760.   
Recruitment and Eligibility  
Recruitment  
Subjects were recruited from general practices and by way of advertisements in  
Manchester, England from 1/2016 through 6/2017  
Inclusion Criteria  
We instituted the following eligibility criteria: age 40-85; severity of overall knee pain in 
the last week of >4 on a 0-10 numerical grading scale (overall knee pain is the primary outcome 
of the trial), Kellgren & Lawrence grade 2-4 in the painful knee (as scored by a musculoskeletal 
radiologist) on a PA or AP radiograph obtained within the last 2 years that showed definite 
medial but no definite lateral narrowing. Patellofemoral osteoarthritis must be less severe than 
medial OA and could not be Kellgren & Lawrence grade 3 or higher there.  
Additional inclusion criteria included: medial joint line tenderness on examination by an 
experienced physical therapist (MJC) with tenderness over the patella less than medial 
tenderness; stable medication regimen for three months; and willingness to wear insoles in 
shoes at least 4 hours daily.   
 
Exclusion Criteria  
Subjects were excluded for the following reasons: a history of high tibial osteotomy, 
other realignment surgery or a knee replacement in the painful knee; a knee arthroscopy within 
the last 6 months or an intraarticular injection of either steroid or viscosupplementation in that 
knee within the last 3 months. Persons with the following disorders or conditions were 
excluded: rheumatoid arthritis or other inflammatory arthritis, diabetic neuropathic pain or 
fibromyalgia; foot or ankle problems that contraindicated the use of footwear load-modifying 
interventions; or severe coexisting medical morbidities. Further exclusions included: inability 
to walk unaided without a crutch, cane or walker; BMI >= 35; and persons who currently used 
or required foot orthoses. We also excluded those unable to retain information regarding study 
procedures or who were unable to walk 100 meters without stopping. A secondary outcome 
of the study was change in MRI features, and those with contraindications to MRI were also 
excluded, as were those who planned knee surgery within the next 6 months.  
Evaluation and Treatment  
For eligible subjects, a gait laboratory appointment was made. There, subjects were 
randomized remotely to the order of testing of insoles in their shoes (no insole, neutral insole, 
lateral wedge insole). A 10 camera Qualisys (Gothenburg, Sweden) Proreflex motion analysis 
system operating at 100 Hz and two Kistler (Alton, UK) force plates operating at 1000 Hz was 
used to measure kinematics and kinetics. Each participant completed a minimum of five 
successful trials (a successful trial was when a single foot contacted the force plate). The 
CAST marker set technique (9) was employed (8). Retroreflective markers were mounted 
securely to the participants’ shoes with the foot modelled as a rigid segment. Ankle and knee 
joint centres were calculated as midpoints between the malleoli and femoral epicondyles 
respectively. The hip joint centre was calculated using the regression model of Bell et al (10) 
based on anterior and posterior superior iliac spine markers. Participants walked at their self-
selected speed and this did not differ across conditions. Using an inverse dynamic approach 
Visual 3D (C-Motion, Rockville, Maryland), we calculated the first peak  
KAM normalized to the participant’s mass (Nm/kg) averaged across the 5 trials. In addition, 
subjects were asked about comfort of each condition and whether they noted any immediate 
effect on knee pain.  
We characterized a subject as a biomechanical responder if, for the study knee, there 
was at least a 2% reduction of their KAM in the lateral wedge insole compared to both the 
KAM in their own shoe and the KAM when they used the neutral insole. Biomechanical 
responders were eligible for the study. We chose a 2% reduction as this is above the minimal 
detectable difference in KAM (11) and was a reasonable approach to ensure biomechanical 
response  
Eligible subjects were randomized by a statistician who had no contact with study staff 
and created sealed opaque envelopes for each study ID number opened when a subject 
entered the study. The randomized allocation list used to create the envelopes was a single-
allocation computer-generated list of balanced permuted blocks with a block size of 6. Study 
staff were blinded to block size. Subjects were randomized to one of two treatment sequences 
1:1 (AB or BA) in a two-period crossover trial. Each randomized participant was provided either 
(A) a 5° lateral wedge insole or (B) a neutral insole, for 8 weeks before an 8 week washout. 
Then, they switched to the other treatment for 8 weeks. The initial treatment was taken away 
at the last visit of the assigned treatment period, preventing treatment contamination. Both 
insoles had a density of 70 Shore A.  
Participants attended the clinic for 5 visits: a screening visit (-2 weeks), baseline visit 
(week 0), post-treatment visit (8 weeks), post-washout visit/second baseline visit (16 weeks), 
and second post treatment visit (24 weeks).   
Participants were asked to wear insoles at least 4 hours per day but could wear them 
for as long as they wanted.   
Bone marrow lesions (BMLs) appear on knee MRI in regions where excessive loading 
has produced bone damage. Medial lesions predominate in those with medial OA.  
BMLs in the patellofemoral joint shrank over 6 weeks when focal loading there was reduced 
(12), suggesting BMLs may respond to unloading treatments. We evaluated subjects for 
change in BML volume in the medial joint. At baseline, subjects underwent MRI of their study 
knee and then obtained MRI’s again at 8, 16 and 24 weeks. Using a 3 T Philips Achieva 
scanner (Philips, Best Netherlands), we obtained sagittal images with SPAIR fat 
suppression, repetition time (TR) 4300ms, echo time (TE) 50ms, Field of View (FOV)  
16x24cm, 212x220 acq matrix, slice thickness 3mm with 0.3mm gap BW 621-655 Hz/pixel.  
Outcomes: Pain  
The primary pre-specified symptom outcome was overall pain in the knee in the past 
week scored using a numerical rating scale (0-10) as per recommendations of the IMMPACT 
group (13). Also, at baseline, subjects were asked to identify the activity that provoked the 
most knee pain and were asked to score pain during this activity at each visit) (14). Lastly, we 
administered the KOOS questionnaire at each visit (15).  
Outcomes : Structure  
Technicians at iMorphics, blinded to treatment assignment, manually segmented BML 
volumes in paired images from each subject’s knee. BMLs were outlined on each MRI slice 
and the volume integrated over all slices. For sagittal images, on which we based results, 
they segmented BMLs in patella, femur and tibia. Interobserver reliability for BML volume 
was ICC = 0.91 (p <0.001) (12).  
The primary structural outcome was change in medial BMLs. We defined these as BMLs 
involving either the tibia medial to the cruciate ligaments or femur medial to the notch using 
regions derived from the WORMS scale (16).  
Analysis:  
The analysis followed an intention-to-treat approach. Multiple imputation by chained 
equations (MICE) was used to correct estimates for bias due to missing data, assuming data 
was missing at random.  
To assess the difference in treatment effects between the two insoles, we used 
maximum likelihood mixed-effects multiple linear regression models. The primary analysis 
model used overall pain in the last week, measured at the end of each treatment visit as the 
outcome and adjusted for baseline (pre-treatment visit) pain scores. Using the baseline value 
as a covariate (the ANCOVA approach) is a recommended methodology with less bias and 
greater power to detect differences (17). Participant ID was included as a random effect. To 
test for carry-over effects, we included three additional covariates: a treatment term, a period 
term, and, the term testing for carryover, a treatment-by-period interaction term. We ran a 
second model identical to the first that removed the period, and treatment-by-period interaction 
terms.  
The same regression models were used to analyse the secondary outcomes, using the 
same terms, but replacing overall knee pain in the last week with the secondary outcome of 
interest.  
In addition to evaluating the response to insoles on a continuous scale, we also defined 
responders as those who achieved an accepted minimally important difference in overall knee 
pain of 1 on the 0-10 point scale (18). We examined what the percentage of trial participants 
achieved responder status as the improvement in pain from baseline pain score in that 
treatment period to the pain score at the end of the period.  
Sample Size  
We aimed to detect a treatment effect size (delta) of 0.4 SDs with 80% power (two 
sided alpha = 0.05). Based on a within-person SD of 2.4 for overall pain in the last week (19) 
testing a lateral wedge insole, this effect size represents a difference of 1.0 point on this knee 
pain rating scale and translates to a sample size of 52 subjects completing the trial. We 
assumed 10% loss to follow-up and aimed to randomize 58 subjects.  
The protocol was approved by National Research Ethics Service Committee North  
West (Preston).  
RESULTS  
Of 83 participants who satisfied inclusion criteria and were evaluated in the gait 
laboratory (Figure 1), 62 were biomechanical responders. In this group, the mean reduction in 
KAM compared with the neutral insole was 6.6% and compared with their own shoe was 7.5% 
(Table 1). In contrast, 21 participants (25.3%) were biomechanical non-responders and, on 
average, their KAM was 2% higher with the lateral wedge insoles than with their own shoes 
(Table 1). There were no differences between responders and non-responders in immediate 
knee pain on walking in the lab or in the comfort of their own shoes vs. inserts. Randomized 
participants were on average 64 years old, had an average BMI of 28, and the majority were 
men (Table 2). Of the 62 randomized, 59 completed the first and 56 the second treatment 
period.  
We found no significant evidence of carry-over effects for any of the outcomes of 
interest. When we examined our primary outcome (Figure 2 and Table 3), we found that 
subjects reported less knee pain when randomized to lateral wedge insoles than when on 
neutral insoles (difference in pain score 0.7 on a 0-10 scale (95%CI 0.1, 1.2; p = 0.02). The 
pain during their most painful nominated activity was also less during the period on lateral 
wedge insoles (Table 3). However, we did not find significant differences for the KOOS pain 
score or the other KOOS subscales.  
We found no effect of treatment on medial bone marrow lesion volume or on total  
BML volume in the knee (Table 3).  
Results from complete case analyses were similar.  
During their period on active treatment, 28% of participants (16/57) achieved a 
minimally important improvement, and on neutral insoles, 22% (13/58) experienced this level 
of improvement. The odds ratio for achieving important improvement on lateral wedges vs. 
neutral inserts was 1.35 (95% 0.58, 3.13, p = 0.49).  
At the end of the first treatment period, participants reported mean insole use of 7.10 
hrs/day (SD 2.72), and at the end of the second, participants reported use of 7.80 hrs/day 
(SD 3.17).  
During the trial, 7 participants experienced side effects leading to temporary (3) or 
permanent (4) treatment discontinuation. Of these, 4 occurred during lateral wedge and 3 
during neutral insole treatment. Of the 2 who discontinued treatment on lateral wedge insoles, 
one had calf pain at night and the other experienced worse knee pain. Of the 2 stopping neutral 
insoles, one developed a toe blister and the other had worsening knee pain.  
DISCUSSION  
In this trial, we prescreened subjects to select biomechanical responses to lateral 
wedge insoles. When we excluded persons who had either patellofemoral involvement or 
failed to show biomechanical responses to insoles, we detected a small effect of insoles on 
pain reduction that was missed in previous trials in which there was no prescreening. However, 
most participants in the trial did not experience a level of improvement that would qualify as  
minimally important based on accepted thresholds. While this trial suggests an approach to 
detect efficacy of this treatment, the efficacy was not sufficient to recommend this treatment 
and the screening approach we used. In this case, we may have found a treatment that shows 
statistical without clinical significance.   
The small treatment effect we found may account for the lack of consistency across 
outcomes. While the lateral wedge insole reduced knee pain based on our primary outcome, 
knee pain over the past week and also led to a reduction in the patient’s nominated painful 
activity, it did not significantly reduce pain or self-reported function assessed using the  
KOOS survey, an expanded version of the Western Ontario McMaster Universities 
Osteoarthritis Index (WOMAC). We have reported that WOMAC is not as sensitive to change 
as global questions about knee pain (14) and that may partly explain the lack of effect. 
However, this lack of effect also suggests that the treatment effect was modest. For the 
primary outcome, the effect size calculated as a standardized response mean was 0.30. This 
effect is comparable to that found for nonsteroidal drugs vs. acetaminophen in OA (20). While 
a validated estimate of minimally important improvement (18) for our primary outcome is 1.0,  
the mean difference in pain reduction between the lateral wedge and neutral insole periods of 
treatment was only 0.7.   
Our screening process utilized a gait laboratory to identify participants with a 
biomechanical response to wedges. Such laboratory evaluations are expensive and may not 
be widely available. Clinical screening protocols could be developed that might identify with 
high probability those likely to respond. We have tried to develop such a protocol without 
success (21), but other efforts are needed. While the KAM measures the medial vs. lateral 
load, another factor affecting medial joint loading is the knee flexion moment. We have 
previously reported that the lateral wedge used in this study does not affect this moment  
(22).  
Once patellofemoral OA is ruled out by a simple physical examination, given the low 
cost and benign safety profile of these wedges, it might be argued that treating patients with 
these insoles is a reasonable clinical strategy rather than seeking a gait laboratory evaluation. 
Even so, the treatment effect is likely to be small and only a few patients will note substantial 
benefit.  
Could the effect of lateral wedge insoles have been similar to that seen in previous 
trials that used WOMAC or KOOS as outcomes? In two large studies using variable stiffness 
shoes or lateral wedge insoles, authors (5, 19) used the same global knee pain measure and 
found no effect of treatment vs. control on pain.  
Osteoarthritis has been challenging to treat because it combines mechanopathology 
with an inflammatory response to joint injury, both of which contribute to pain and disease 
progression. It has been unclear whether nonsurgical treatments targeting pathomechanics 
were likely to be major elements of the treatment armamentarium. Knee brace adherence is 
poor, for example. Our study offers modest promise for a simple, inexpensive treatment. 
Further refinement of the treatment with use of specific shoes or increases in the degree of 
wedging may increase efficacy.  
We and others have reported that biomechanical response to lateral wedge insoles is 
variable (22, 24, 25). Although the reasons are unclear, one study (25) suggests that stiffness 
in feet and ankles in some persons may prevent the lateral ankle eversion that is necessary 
for knee loading to change with this treatment.  
While lateral wedge insoles are thought to be safe treatments, their use occasionally 
(21) generates complaints of discomfort in the shoe and may cause back pain (19). We did 
not find major safety concerns, and no one discontinued treatment due to back pain.  
We carried out a crossover trial to evaluate the effect of lateral wedge insoles. 
Crossover trials permit the testing of treatments more efficiently than parallel design trials and 
make it easier to detect modest effects of treatments.   
In summary, we found, for the first time, that lateral wedge insoles may be modestly 
effective in reducing pain in persons with medial knee OA. However, the treatment effect was 
small and most treated patients did not achieve conventional levels of minimal important 
response.  Future modifications of the treatment or of the screening strategy might offer greater 
levels of efficacy.  
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Key Messages:  
1. Trials testing lateral wedge vs. neutral insoles in persons with painful medial knee 
osteoarthritis  have shown no reduction in knee pain despite a proven reduction in 
medial loading.  
2. The biomechanical response to lateral wedges is inconsistent with roughly 25% of 
persons showing no reduction in medial loading, and shifting load laterally may worsen 
patellofemoral loading.  
3. This trial prescreened subjects with painful medial OA to remove those with 
patellofemoral disease and those who did not show a reduction in medial knee  
loading with lateral insoles.   
4. While the trial showed a reduction in the primary pain outcome, this effect was small 
and other measures of pain showed no effect, nor was there a reduction in local bone 
marrow lesions on MRI, a measure of medial load.  
5. Even after prescreening, lateral wedge insoles, at least as conventionally used,  do not 
produce important improvement in pain in most persons. 
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Table 1.  Percent difference in responders vs. non-responders in external Knee Adduction Moment (KAM) using lateral wedge  
insoles vs. neutral insoles and vs. participant’s own shoes  
 Own Shoe  Neutral  
Insole  
Lateral Wedge  
Insole  
Difference Between  
Own Shoe and LWI  
Difference Between  
Neutral Insole and  
LWI  
 mean (SD)  mean (SD)  mean (SD)  Adjusted mean  
(95% CI)  
adjusted mean   
(95% CI)  
Absolute Values  
% Change Non-
Responders (N=21)  
0.54 (0.17)  
-  
0.54 (0.16)  
-  
0.55 (0.17)  
-  
0.01 (0.00 to 0.02)  
1.98 (-0.07 to 4.03)  
0.00 (-0.01 to 0.02)  
0.64 (-2.12 to 3.39)  
Immediate Pain  2.86 (2.46)  2.33 (2.35)  2.05 (2.09)  -0.78 (-1.28 to -0.28)  -0.27 (-0.77 to 0.23)  
Immediate Comfort*  
Absolute Values  
% Change Responders 
(N=62)  
7.29 (1.74)  7.10 (2.21)  7.62 (1.77)  0.35 (-0.18 to 0.88)  0.22 (-0.32 to 0.75)  
0.50 (0.15)  
-  
0.49 (0.15)  
-  
0.46 (0.14)  
-  
-0.04 (-0.04 to -0.03)  
-7.54 (-8.53 to -6.55)  
-0.03 (-0.04 to -0.03)  
-6.56 (-7.69 to -5.42)  
Immediate Pain  3.03 (2.21)  2.84 (2.06)  2.48 (1.89)  -0.28 (-0.57 to 0.02)  -0.18 (-0.48 to 0.11)  
Immediate Comfort*  7.00 (1.87)  7.32 (1.94)  7.44 (1.77)  0.14 (-0.21 to 0.49)  0.12 (-0.22 to 0.47)  
Immediate pain and comfort graded on a 0-10 scale but for pain, lower numbers represent less pain and for comfort, higher scores represent 
more comfort.   
Table 2.  Characteristics of responders and non-responders  
 
Responders  
 (N=62)  Non-Responders (N=21)  
Variable 
 
Age in years  
mean 
(SD)  64.18 (9.10)  65.86 (10.03)  
BMI 
mean 
(SD)  28.21 (3.44)  28.56 (3.99)  
No. females (%)   23 (37.10)  9 (42.86)  
HAD* Anxiety Score  
mean 
(SD)  12.17 (2.24)  12.48 (1.57)  
HAD* Depression Score  
mean 
(SD)  9.10 (1.24)  8.33 (0.97)  
Overall Knee Pain in last week NRS (0-10)  
mean 
(SD)  5.26 (1.63)  5.24 (1.87)  
Pain on nominated activity NRS (0-10)  
mean 
(SD)  6.18 (1.54)  6.05 (1.66)  
KOOS Pain Subscale Score (0-100)ɸ  
Kellgren and Lawrence Grade of 
Studied Knee (%)  
mean 
(SD)  
55.20 (13.45)  58.07 (12.07)  
-Grade 2  17 (27.4%)   
-Grade 3  37 (59.7%)   
-Grade 4  8 (12.9%)   
 
*Hospital Anxiety and Depression Scale. Scores range from 0-21 with higher scores (above 
11) indicating either depression or anxiety 
ɸKOOS scores range from 100 to 0 where 100 represents no pain/difficulty.  
Table 3.  Comparison between lateral wedge and neutral insoles after 8 weeks' treatment**  
 
  Post-Treatment Adjusted Mean (95% CI)   Difference between treatments  
 
Outcome  Lateral Wedge Insole  Neutral Insole   (mean, 95% CI, p)  
Pain in last week*  4.16 (3.69 to 4.62)  4.85 (4.42 to 5.28)  0.70 (0.12 to 1.27), 0.02  
Pain in nominated activity*  4.80 (4.30 to 5.31)  5.77 (5.28 to 6.26)  0.97 (0.32 to 1.61), 0.003  
KOOS Pain subscale score*  60.66 (57.21 to 64.11)  58.82 (55.67 to 61.96)  -1.84 (-6.31 to 2.62), 0.42  
KOOS Symptom subscale score  60.64 (57.59 to 63.70)  59.41 (56.40 to 62.42)  -1.23 (-5.11 to 2.65), 0.53  
KOOS Activities of Daily Living subscale 
score  66.29 (63.15 to 69.44)  65.01 (61.88 to 68.14)  -1.28 (-5.19 to 2.62), 0.52  
KOOS Sports & Recreation subscale score  
43.57 (39.46 to 47.67)  42.21 (37.56 to 46.86)  -1.36 (-6.97 to 4.26), 0.63  
KOOS Quality of Life subscale score  44.18 (40.62 to 47.73)  44.09 (40.80 to 47.38)  -0.09 (-4.64 to 4.47), 0.97  
Total BML Volume  12959.66 (10991.04 to 14928.29)  11047.29 (8833.52 to 13261.05)  -1912.38 (-4602.61 to 777.86), 0.16  
Medial TF BML Volume  8331.48 (6903.42 to 9759.55)  7051.42 (5398.37 to 8704.47)  -1280.07 (-3210.91 to 650.78), 0.19  
Lateral TF BML Volume  1340.93 (801.87 to 1879.99)  1219.47 (648.63 to 1790.32)  -121.45 (-630.27 to 387.36), 0.64  
*For pain in last week and pain in nominated activity, lower scores represent pain reduction. For KOOS higher scores represent pain reduction. 
**Pain and other scores in the table are adjusted for the baseline value of that outcome which is the same for both treatment groups.  
 
 
